Candong, Norhana B.
HRN: 11-30-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/27/2025
07/03/2025
IVTT
500mg
Every 8hrs
T/C Acute Cholecystitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes